ADRB2 |
P07550
|
adrenoceptor beta 2
|
G-protein coupled receptor
|
0.53 |
0.442 |
0.923 |
AFP |
P02771
|
alpha fetoprotein
|
Transporter
|
1.1E-11 |
0.429 |
0.885 |
APC |
P25054
|
APC regulator of WNT signaling pathway
|
|
1.00 |
0.373 |
0.962 |
APEX1 |
P27695
|
apurinic/apyrimidinic endodeoxyribonuclease 1
|
|
1.9E-07 |
0.458 |
0.846 |
ARID1A |
O14497
|
AT-rich interaction domain 1A
|
|
1.00 |
0.455 |
0.846 |
ATM |
Q13315
|
ATM serine/threonine kinase
|
Kinase
|
5.6E-47 |
0.374 |
0.885 |
BAP1 |
Q92560
|
BRCA1 associated protein 1
|
Enzyme
|
0.99 |
0.454 |
0.731 |
BIRC5 |
O15392
|
baculoviral IAP repeat containing 5
|
Enzyme modulator
|
5.6E-02 |
0.495 |
0.731 |
CCAT1 |
|
colon cancer associated transcript 1
|
|
|
0.585 |
0.500 |
CCND1 |
P24385
|
cyclin D1
|
Enzyme modulator
|
0.89 |
0.344 |
0.923 |
CD44 |
P16070
|
CD44 molecule (Indian blood group)
|
|
2.4E-07 |
0.363 |
0.962 |
CDH1 |
P12830
|
cadherin 1
|
|
0.15 |
0.401 |
0.808 |
CDKN1A |
P38936
|
cyclin dependent kinase inhibitor 1A
|
|
1.9E-03 |
0.403 |
0.769 |
CDKN2A |
P42771 Q8N726
|
cyclin dependent kinase inhibitor 2A
|
|
0.39 |
0.300 |
0.885 |
CDX2 |
Q99626
|
caudal type homeobox 2
|
Transcription factor
|
0.53 |
0.458 |
0.769 |
CLDN3 |
O15551
|
claudin 3
|
Cell-cell junction
|
0.52 |
0.558 |
0.615 |
CTNNB1 |
P35222
|
catenin beta 1
|
|
1.00 |
0.303 |
0.885 |
CXCL8 |
P10145
|
C-X-C motif chemokine ligand 8
|
Signaling
|
2.7E-04 |
0.310 |
0.962 |
CYP2A6 |
P11509
|
cytochrome P450 family 2 subfamily A member 6
|
|
5.4E-09 |
0.556 |
0.731 |
EGFR |
P00533
|
epidermal growth factor receptor
|
Kinase
|
0.37 |
0.295 |
0.885 |
ENO1 |
P06733
|
enolase 1
|
Enzyme
|
1.9E-05 |
0.481 |
0.885 |
ERBB2 |
P04626
|
erb-b2 receptor tyrosine kinase 2
|
Kinase
|
6.0E-03 |
0.328 |
0.923 |
ERCC1 |
P07992
|
ERCC excision repair 1, endonuclease non-catalytic subunit
|
Enzyme
|
1.6E-07 |
0.445 |
0.846 |
FAT4 |
Q6V0I7
|
FAT atypical cadherin 4
|
|
1.00 |
0.539 |
0.808 |
FGFR2 |
P21802
|
fibroblast growth factor receptor 2
|
Kinase
|
1.00 |
0.380 |
0.808 |